Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
- ( )
Saxenda (liraglutide for obesity) is an older obesity-approved GLP-1 and is subject to the same optional coverage rules as Wegovy and Zepbound
Genesis Rivas is the Beauty Editor at Oprah Daily, where she covers hair, makeup, skin, nails, and more
We focus on what works
Additionally, a meta-analysis of various clinical trials, published in the "Journal of Obesity," concluded that GLP-1 receptor agonists were associated with a significant reduction in body weight
Many inhibitors also have off-target effects, which become more pronounced at high concentrations
US$ 26.71
US$ 29.28
US$ 27.74
